|
2026
|
G/S
|
Pharmaceutical and biological preparations; Pharmaceutical and biological preparations formulated... |
|
2025
|
Invention
|
Polypeptides, polynucleotides, compositions, and methods for genome editing involving chromatin r... |
|
|
Invention
|
Compositions and methods for treating alpha-1 antitrypsin deficiency.
Compositions and methods f... |
|
|
Invention
|
Compositions and methods for kallikrein (klkb1) gene editing.
Compositions and methods for editi... |
|
|
G/S
|
Pharmaceutical and biological preparations for the treatment of hereditary angioedema (HAE); Phar... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of hereditary angioedema; Pharmaceutical and biolog... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of hereditary angioedema
Pharmaceutical and biologi... |
|
|
Invention
|
Stabilized nucleic acids encoding messenger ribonucleic acid (mrna).
This disclosure relates to ... |
|
|
Invention
|
Modified guide rnas.
This disclosure relates to modified single and dual guide RNAs having impro... |
|
|
Invention
|
Modified guide rnas for genome editing. This disclosure relates to modified guide RNAs having imp... |
|
|
Invention
|
Compositions and methods for hydroxyacid oxidase 1 (hao1) gene editing for treating primary hyper... |
|
|
Invention
|
Systems and methods for genomic editing.
Methods and compositions for genetically modifying a ce... |
|
|
Invention
|
Compositions and methods for proprotein convertase subtilisin kexin 9 (pcsk9) editing.
The prese... |
|
|
Invention
|
Cd8 co-receptor chimeric polypeptides in tcr cell therapy. Chimeric CD8 polypeptides, engineered ... |
|
|
Invention
|
Compositions and methods for lactate dehydrogenase (ldha) gene editing.
Compositions and methods... |
|
|
Invention
|
Lipid nanoparticles and lipid nanoparticle compositions. Lipid nanoparticles comprising ionizable... |
|
|
Invention
|
Methods of synthesizing amine lipids. Described herein are methods of synthesizing ionizable amin... |
|
|
Invention
|
Compositions and methods for angiopoietin like 3 (angptl3) editing. ANGPTL3ANGPTL3ANGPTL3ANGPTL3A... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of hereditary angioedema |
|
|
Invention
|
Compositions and methods for kallikrein (klkb1) gene editing. Compositions and methods for editin... |
|
2024
|
Invention
|
Compositions and methods for expressing factor ix.
Compositions and methods for expressing Facto... |
|
|
Invention
|
Engineered t cells. The present disclosure relates to T cells engineered to comprise a heterologo... |
|
|
Invention
|
Methods for rapid engineering of cells. Methods and compositions for rapid engineering of cells a... |
|
|
Invention
|
Compositions and methods for genomic editing.
Compositions and methods for ex vivo genomic editi... |
|
|
Invention
|
Methods and compositions for genetically modifying a cell.
Methods and compositions for genetica... |
|
|
Invention
|
Compositions and methods for reducing mhc class i in a cell.
Compositions and methods for reduci... |
|
|
Invention
|
Compositions, methods, and systems for genomic editing. The present disclosure relates to composi... |
|
|
Invention
|
Compositions and methods for ttr gene editing and treating attr amyloidosis.
Compositions and me... |
|
|
Invention
|
Nuclease resistant double stranded dna product for non-viral delivery to a cell and methods of pr... |
|
|
Invention
|
Nuclease resistant single stranded dna product for non-viral delivery to a cell and methods of pr... |
|
|
Invention
|
Methods for editing hla-a in cells pre-screened for the absence of one or both alleles of hla-h*0... |
|
|
Invention
|
Methods of editing an hla-a gene in vitro. in vitroin vitro, edited cells, and populations of edi... |
|
|
Invention
|
Compositions and methods for genetically modifying transforming growth factor beta receptor type ... |
|
|
Invention
|
Cd70 car-t compositions and methods for cell-based therapy |
|
|
Invention
|
Compositions and methods for genetically modifying cd70 |
|
|
Invention
|
Compositions and methods for genetically modifying cd70. Compositions and methods for editing, e.... |
|
|
Invention
|
Cd70 car-t compositions and methods for cell-based therapy. Compositions and methods described he... |
|
|
Invention
|
Modified amine lipids.
The disclosure provides ionizable amine lipids and salts thereof (e.g., p... |
|
|
G/S
|
Licensing of intellectual property rights related to gene, genome, and cellular editing technology |
|
|
G/S
|
Research and development in the field of gene, genome, or cellular editing technology for medical... |
|
|
Invention
|
Assays for analysis of ribonucleic acid (rna) molecules. In certain aspects, the disclosure relat... |
|
|
Invention
|
Systems, devices, and methods of a data pipeline. Disclosed are data pipelines for string extract... |
|
|
Invention
|
Ionizable amine lipids. The disclosure provides ionizable lipids and lipid nanoparticle (LNP) com... |
|
|
G/S
|
Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of ... |
|
|
Invention
|
Compositions and methods for treatment of diseases associated with trinucleotide repeats in trans... |
|
2023
|
Invention
|
Compositions and methods for immunooncology.
The present invention is directed to genome editing... |
|
|
Invention
|
Compositions and methods for immunooncology.
The present disclosure is directed to genome editin... |
|
|
Invention
|
Chimeric antigen receptor compositions and uses.
Compositions and methods for expressing a chime... |
|
|
Invention
|
Crispr-mediated transgene insertion in neonatal cells.
Compositions and methods for inserting a ... |
|
2022
|
Invention
|
Cd38 compositions and methods for immunotherapy.
Compositions and methods for editing, e.g., alt... |
|
|
Invention
|
Methods for in vivo editing of a liver gene.
The first systemic administration of a CRISPR/Cas9-... |
|
|
Invention
|
Lipid nanoparticle compositions.
The disclosure provides lipid nanoparticle (LNP) compositions o... |
|
2016
|
G/S
|
Pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells base... |
|
2015
|
G/S
|
Pharmaceutical and biological preparations based on gene, genome and cellular editing, modulation... |
|
|
G/S
|
Pharmaceutical and biological preparations and diagnostic
products based on gene, genome and cel... |
